R. Goldschmidt

发表

Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000

K. Bush, A. Evangelista, D. Sahm, 2002, Antimicrobial Agents and Chemotherapy.

Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.

K. Bush, B. Foleno, M. Macielag, 2009, Bioorganic & medicinal chemistry letters.

Novel Ser79Leu and Ser81Ile Substitutions in the Quinolone Resistance-Determining Regions of ParC Topoisomerase IV and GyrA DNA Gyrase Subunits from Recent Fluoroquinolone-Resistant Streptococcus pneumoniae Clinical Isolates

T. Davies, R. Goldschmidt, N. Korzheva, 2005, Antimicrobial Agents and Chemotherapy.

Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

K. Bush, A. Evangelista, D. Sahm, 2003, The Journal of antimicrobial chemotherapy.

In vivo Degradation of Nonsense Fragments in E. coli

R. Goldschmidt, 1970, Nature.

Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).

K. Bush, A. Evangelista, D. Sahm, 2006, The Journal of antimicrobial chemotherapy.

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.

K. Bush, C. Fogarty, R. Goldschmidt, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of fluoroquinolones against gram-positive bacteria.

K. Bush, R. Goldschmidt, 2000, Current opinion in investigational drugs.

Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae.

K. Bush, A. Evangelista, D. Sahm, 2008, Microbial drug resistance.

Avirulent Salmonella typhimurium Δcya Δcrp oral vaccine strains expressing a streptococcal colonization and virulence antigen

R. Curtiss, R. Goldschmidt, S. Kelly, 1988 .

Identiﬁcation of a Dithiazoline Inhibitor of Escherichia coli L , D -Carboxypeptidase A

K. Bush, E. Baum, B. Foleno, 2005 .

In Vitro Antibacterial Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

K. Bush, Steven D. Paget, B. Foleno, 2006, Antimicrobial Agents and Chemotherapy.

Polypeptide products of nonsense mutations. II. Minor fragments produced by nonsense mutations in the z gene of the lactose operon of Escherichia coli.

D. Zipser, S. Morrison, R. Goldschmidt, 1971, Journal of molecular biology.

Antibacterial activity of pyrrolopyridine-substituted oxazolidinones: synthesis and in vitro SAR of various C-5 acetamide replacements.

K. Bush, Steven D. Paget, B. Foleno, 2006, Bioorganic & medicinal chemistry letters.

Multiple Mechanisms of Action for Inhibitors of Histidine Protein Kinases from Bacterial Two-Component Systems

K. Bush, E. Baum, Lisa Licata, 1999, Antimicrobial Agents and Chemotherapy.

Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinones.

K. Bush, Steven D. Paget, B. Foleno, 2003, Bioorganic & medicinal chemistry letters.

SAR studies of diaryltriazoles against bacterial two-component regulatory systems and their antibacterial activities.

Z. Sui, B. Foleno, D. Hlasta, 1998, Bioorganic & medicinal chemistry letters.

Novel piperidinyloxy oxazolidinone antibacterial agents. Diversification of the N-Substituent.

K. Bush, B. Foleno, D. Hlasta, 2002, Bioorganic & medicinal chemistry.

Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.

John J. M. Wiener, Cheryl A. Grice, M. Hack, 2007, Bioorganic & medicinal chemistry letters.

7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitors.

K. Bush, Shu-chen Lin, Steven D. Paget, 2014, Bioorganic & medicinal chemistry letters.

Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae

Lisa Licata, J. Barrett, R. Goldschmidt, 1997, Antimicrobial agents and chemotherapy.

Antibacterial agents that inhibit two-component signal transduction systems.

J. Hoch, R. Kanojia, D. Klaubert, 1998, Proceedings of the National Academy of Sciences of the United States of America.

The synthesis and antimicrobial evaluation of a new series of isoxazolinyl oxazolidinones.

K. Bush, B. Foleno, M. Macielag, 2004, Bioorganic & medicinal chemistry letters.

The Genomics Approach: Is it Really the Solution?

K. Bush, R. Goldschmidt, 2001 .

Utility of Muropeptide Ligase for Identification of Inhibitors of the Cell Wall Biosynthesis Enzyme MurF

K. Bush, E. Baum, B. Foleno, 2006, Antimicrobial Agents and Chemotherapy.

Biohazard Assessment of Recombinant DNA Molecule Research

R. Curtiss, M. Inoue, R. Goldschmidt, 1977 .

Inhibitors of bacterial two-component signalling systems

M. Macielag, R. Goldschmidt, Mark J Macielag, 2000, Expert opinion on investigational drugs.

Potential of Escherichia coli isolated from nature to propagate cloning vectors

R. Curtiss, R. Goldschmidt, J. Robeson, 1980, Nature.

In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

K. Bush, M. Macielag, J. Hilliard, 2009, Antimicrobial Agents and Chemotherapy.

Identification of a Dithiazoline Inhibitor of Escherichia colil,d-Carboxypeptidase A

K. Bush, Sean X Peng, E. Baum, 2005, Antimicrobial Agents and Chemotherapy.

Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.

R. Kanojia, R. Russell, Z. Sui, 1998, Journal of medicinal chemistry.

Screening of large numbers of Streptococcus pneumoniae isolates for mutations associated with fluoroquinolone resistance using an oligonucleotide probe assay.

T. Davies, R. Goldschmidt, 2002, FEMS microbiology letters.